Repetitive transcranial magnetic stimulation in the treatment of middle-aged and elderly major depressive disorder: A randomized controlled trial

医学 磁刺激 依西酞普兰 随机对照试验 内科学 重性抑郁障碍 抗抑郁药 神经心理状态评估的可重复电池 心情 精神科 刺激 认知障碍 疾病 海马体
作者
Xiaofang Wang,Xianqun Fan,Lihui Zhang,Xin Liu,Zhi Gang Ji
出处
期刊:Medicine [Ovid Technologies (Wolters Kluwer)]
卷期号:102 (35): e34841-e34841
标识
DOI:10.1097/md.0000000000034841
摘要

Studies have reported the use of repetitive transcranial magnetic stimulation (rTMS) in patients with major depressive disorder (MDD). However, most studies focus on antidepressant effect of rTMS, but few on cognitive aspects. The present study aimed to explore the effect of rTMS on BDNF levels and cognitive function in the treatment of middle-aged and elderly MDD.This was a randomized controlled trial. A total of 120 elderly patients with MDD treated in The Second Affiliated Hospital of Xi'an Medical University from January 2021 to January 2023 were selected as research subjects. The patients were randomly divided into control group (n = 60, patients received simple oral treatment with escitalopram and sham rTMS) and study group (n = 60, patients received oral treatment with escitalopram combined with rTMS) according to the random number table method. We compared the clinical efficacy, serum BDNF levels, and cognitive function between the 2 groups.After treatment, the HAMD-17 score in the study group was lower than that in the control group [13.00 (12.00-16.00) vs 17.00 (15.00-19.00), P < .05], and the RBANS score was higher than that in the control group [166.00 (161.25-171.75) vs 133.00 (130.00-136.75), P < .05]. The total effective rate of the research group was 95.0%, which was higher than the 82.0% of the control group (P < .05). The serum BDNF levels [36.00 (33.00-38.00) vs 30.00 (28.00-32.00), P < .05] and MoCA scores [24.00 (22.00-26.75) vs 23.00 (21.00-25.00), P < .05] of the study group were higher than those of the control group. There were no significant adverse reactions during the treatment of both groups.Compared with oral escitalopram alone, repeated transcranial magnetic stimulation in the treatment of middle-aged and elderly patients with major depressive disorder can further improve the efficacy, and can more effectively improve the BDNF level and cognitive function, with ideal safety.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
文歌发布了新的文献求助20
1秒前
cn完成签到,获得积分20
1秒前
wyy完成签到,获得积分10
2秒前
Si完成签到,获得积分10
2秒前
小向发布了新的文献求助30
4秒前
cyx2045完成签到,获得积分20
4秒前
qwerty发布了新的文献求助10
4秒前
4秒前
可爱的函函应助果果采纳,获得10
5秒前
miaomiao完成签到,获得积分10
5秒前
QAQ发布了新的文献求助10
5秒前
汉堡包应助无奈素采纳,获得10
6秒前
桐桐应助李皖采纳,获得10
6秒前
6秒前
7秒前
7秒前
8秒前
HEhaha完成签到,获得积分20
8秒前
sleep2333完成签到,获得积分10
9秒前
无花果应助玩命的若采纳,获得10
9秒前
10秒前
minmin发布了新的文献求助10
10秒前
11秒前
拼搏老九完成签到,获得积分10
11秒前
hajf完成签到,获得积分20
11秒前
11秒前
12秒前
Vicky完成签到,获得积分10
12秒前
张叮当发布了新的文献求助10
12秒前
勤劳的芳应助ramsey33采纳,获得50
12秒前
安静的ky完成签到 ,获得积分10
13秒前
HEhaha发布了新的文献求助10
13秒前
13秒前
土豪的雅柔完成签到,获得积分10
14秒前
14秒前
hajf发布了新的文献求助10
15秒前
cistronic完成签到,获得积分10
17秒前
YE发布了新的文献求助10
17秒前
17秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
Impiego dell’associazione acetazolamide/pentossifillina nel trattamento dell’ipoacusia improvvisa idiopatica in pazienti affetti da glaucoma cronico 900
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
錢鍾書楊絳親友書札 600
金属中的晶界偏聚 450
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3296818
求助须知:如何正确求助?哪些是违规求助? 2932518
关于积分的说明 8457314
捐赠科研通 2605021
什么是DOI,文献DOI怎么找? 1422147
科研通“疑难数据库(出版商)”最低求助积分说明 661308
邀请新用户注册赠送积分活动 644397